{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:47:07Z","timestamp":1794062827464,"version":"4.8.0"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21875252"],"award-info":[{"award-number":["21875252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The aim of this study is to find the anticancer lead compounds or drug candidates from Chinese Traditional\nPlant Medicine of Ajuga decumbens Thunb.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Ajuga decumbens Thunb. has been used in clinical for a long time in China and was selected in \u201cChinses\nPharmacopoeia\u201d (part I in 1977) for its wide spectrum biological activities: such as anticancer, antioxidant, antifeedant,\nantibacterial, anti-inflammatory, antihyperlipidemic, anti-cholinesterase and cytotoxicity activities. However, there are\nrelatively fewer studies of Ajuga decumbens Thunb. that have been carried out till now. For some years, our research\ngroup focused on the discovery of new anticancer agents, so we studied the chemical compositions of Ajuga decumbens\nThunb., planted in Pingtan island of Fujian Province, to discover new anticancer lead compounds or candidates\nfrom this Chinese Traditional Plant Medicine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The dichloromethane (DCM) extract was obtained in this work, and then this extract was used for silica gel\ncolumn chromatography to obtain different polar fractions. Several similar fractions were combined according to TLC\nor HPLC analysis. The combined fractions were isolated by preparative TLC or preparative HPLC to obtain the pure\ncompounds and HPLC was used to detect the purity. All isolated compounds were determined by NMR (1HNMR,\n13CNMR, DEPT, HMBC, HSQC, 1H-1H COSY and NOESY), HRESIMS and single crystal X-ray diffraction methods.\nThe in vitro anticancer activity was evaluated using CCK8 method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Seven compounds [three new compounds 1-3\uff1b and four known compounds (Ajugacumbins A, Ajugacumbin\nB, Ajugamarin A2 and Ajugamarin A1)] were isolated from Ajuga decumbens Thunb. in this work, and\ntheir structures were confirmed. The biological evaluation showed that 3 and Ajugamarin A1 exhibited potent in vitro\nanticancer activity both against A549 cell lines with IC50s=71.4 \u03bcM and 76.7 \u03bcM; and against Hela cell lines with\nIC50s=71.6 mM and 5.39\u00d710-7 \u03bcM, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Compounds (3 and Ajugamarin A1) can be regarded as the lead compounds for the development of anticancer\nagents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520622666220620151225","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:44:23Z","timestamp":1655793863000},"page":"237-244","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["New neo-Clerodane Diterpenoids Isolated from Ajuga decumbens Thunb., Planted\nat Pingtan Island of Fujian Province with the Potent Anticancer Activity"],"prefix":"10.2174","volume":"23","author":[{"given":"Jianping","family":"Yong","sequence":"first","affiliation":[{"name":"Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canzhong","family":"Lu","sequence":"first","affiliation":[{"name":"Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian, China"},{"name":"University of Chinese Academy\nof Sciences, Beijing, China"},{"name":"Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olagoke","family":"Zacchaeus Olatunde","sequence":"additional","affiliation":[{"name":"Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian, China"},{"name":"University of Chinese Academy\nof Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Cancer Research UK 2019. Available from:  https:\/\/www.cancerresearchuk.org\/about-cancer\/what-is-cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.armc.2020.02.001","volume":"55","author":"Sarker S.D.","year":"2020","unstructured":"Sarker S.D.; Nahar L.; Miron A.; Guo M.Q.; Anticancer natural products. Annu Rep Med Chem 2020,55,45-75","journal-title":"Annu Rep Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1871520619666181224121004","volume":"19","author":"Gezici S.","year":"2019","unstructured":"Gezici S.; &#x15E;ekero&#x11F;lu, N. Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anticancer Agents Med Chem 2019,19(1),101-111","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms19010263","volume":"19","author":"Seca A.M.L.","year":"2018","unstructured":"Seca A.M.L.; Pinto D.C.G.A.; Plant secondary metabolites as anticancer agents: Successes in clinical trials and therapeutic application. Int J Mol Sci 2018,19(1),263","journal-title":"Int J Mol Sci"},{"key":"ref=5","author":"Nahar L.","year":"2019","unstructured":"Nahar L.; Sarker S.D.;  Chemistry for Pharmacy Students 2019","journal-title":"Chemistry for Pharmacy Students"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1021\/np2001557","volume":"74","author":"Guo P.","year":"2011","unstructured":"Guo P.; Li Y.; Xu J.; Liu C.; Ma Y.; Guo Y.; Bioactive neo-clerodane diterpenoids from the whole plants of Ajuga ciliata Bunge. J Nat Prod 2011,74(7),1575-1583","journal-title":"J Nat Prod"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11101-006-9023-3","volume":"7","author":"Coll J.","year":"2008","unstructured":"Coll J.; Tandron Y.A.; neo-Clerodane diterpenoids from Ajuga: Structural elucidation and biological activity. Phytochem Rev 2008,7(1),25-49","journal-title":"Phytochem Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.phytol.2013.05.017","volume":"6","author":"Xiong Y.","year":"2013","unstructured":"Xiong Y.; Qu W.; Sun J.B.; Wang M.T.; Liang J.Y.; Eudes-mane sesquiterpenoid lactones and abietane diterpenoids from Ajuga forrestii Diels. Phytochem Lett 2013,6(3),457-460","journal-title":"Phytochem Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.steroids.2006.11.017","volume":"72","author":"Coll J.","year":"2007","unstructured":"Coll J.; Tandr&#xF3;n Y.A.; Zeng X.; New phytoecdysteroids from cultured plants of Ajuga nipponensis Makino. Steroids 2007,72(3),270-277","journal-title":"Steroids"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1021\/np800131f","volume":"71","author":"Castro A.","year":"2008","unstructured":"Castro A.; Coll J.; Tandr&#xF3;n Y.A.; Pant A.K.; Mathela C.S.; Phytoecdysteroids from Ajuga macrosperma var. breviflora roots. J Nat Prod 2008,71(7),1294-1296","journal-title":"J Nat Prod"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/1934578X1200700518","volume":"7","author":"Hussain J.","year":"2012","unstructured":"Hussain J.; Begum N.; Hussain H.; Khan F.U.; Rehman N.U.; Al-Harrasi A.; Ali L.; Ajuganane: A new phenolic com-pound from Ajuga bracteosa. Nat Prod Commun 2012,7(5),615-616","journal-title":"Nat Prod Commun"},{"key":"ref=12","first-page":"147","volume":"5","author":"Manguro L.O.A.","year":"2011","unstructured":"Manguro L.O.A.; Lemmen P.; Hao P.; Iridoid glycosides from underground parts of Ajuga remota. Rec Nat Prod 2011,5,147-157","journal-title":"Rec Nat Prod"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1021\/np0104626","volume":"65","author":"Kuria K.A.M.","year":"2002","unstructured":"Kuria K.A.M.; Chepkwony H.; Govaerts C.; Roets E.; Bus-son R.; De Witte P.; Zupko I.; Hoornaert G.; Quirynen L.; Maes L.; Janssens L.; Hoogmartens J.; Laekeman G.; The antiplasmodial activity of isolates from Ajuga remota. J Nat Prod 2002,65(5),789-793","journal-title":"J Nat Prod"},{"key":"ref=14","first-page":"1035","year":"2006","unstructured":"Dictionary of Chi-nese Materia Medica 2006,1035-1037","journal-title":"Dictionary of Chi-nese Materia Medica"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1248\/cpb.37.2505","volume":"37","author":"Min Z.D.","year":"1989","unstructured":"Min Z.D.; Wang S.Q.; Zheng Q.T.; Wu B.; Mizuno M.; Tanaka T.; Iinuma M.; Four new insect antifeedant neo-clerodane diterpenoids, ajugacumbins A, B, C, and D, from Ajuga decumbens. Chem Pharm Bull (Tokyo) 1989,37(9),2505-2508","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fitote.2018.06.004","volume":"129","author":"Chen H.","year":"2018","unstructured":"Chen H.; Tang B.Q.; Chen L.; Liang J.Y.; Sun J.B.; Neo-clerodane diterpenes and phytoecdysteroids from Ajuga de-cumbens Thunb. and evaluation of their effects on cytotoxic, superoxide anion generation and elastase release in vitro. Fitoterapia 2018,129,7-12","journal-title":"Fitoterapia"},{"key":"ref=17","first-page":"7","volume":"21","author":"Cai X.M.","year":"2012","unstructured":"Cai X.M.; Liu Y.; Mu B.; Zeng M.; Yang J.B.; Shen Y.W.; Chen B.F.; Liang S.H.; Study on antihyperlipidemic effect of Ajuga Decumbens Thunb. original extract. China Pharmaceu-ticals 2012,21(15),7-8","journal-title":"China Pharmaceu-ticals"},{"key":"ref=18","first-page":"2937","volume":"24","author":"Zhang B.","year":"2014","unstructured":"Zhang B.; Zeng F.J.; Zhang X.Y.; Study on anti-infection effect of Ajuga. Zhongguo Yiyuan Ganranxue Zazhi 2014,24(12),2937-2939","journal-title":"Zhongguo Yiyuan Ganranxue Zazhi"},{"key":"ref=19","first-page":"565","volume":"31","author":"Xu Y.","year":"2013","unstructured":"Xu Y.; Fang J.; Yu C.H.; Ye H.C.; Inhibition of fractions and compounds from Ajuga decumbens on acetylcholinester-ase activity. Zhonghua Zhongyiyao Xuekan 2013,31(3),565-566","journal-title":"Zhonghua Zhongyiyao Xuekan"},{"key":"ref=20","first-page":"581","volume":"33","author":"Wang J.J.","year":"2017","unstructured":"Wang J.J.; Peng B.; He R.; Xu Q.H.; Han J.Y.; Li J.R.; Pre-liminary research on effect of combination of Ajuga decum-bens and Poria cocos on invasion and metastasis of breast cancer. Zhongguo Yaolixue Tongbao 2017,33(4),581-588","journal-title":"Zhongguo Yaolixue Tongbao"},{"key":"ref=21","first-page":"3511","volume":"36","author":"Peng B.","year":"2011","unstructured":"Peng B.; He R.; Xu Q.; Gao J.; Lu Y.; Li J.; Correlation between antimetastatic action of Ajuga decumbens and ex-pression of MMPs and TIMPs. Zhongguo Zhongyao Zazhi 2011,36(24),3511-3514","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=22","first-page":"30","volume":"13","author":"Zeng M.G.","year":"2003","unstructured":"Zeng M.G.; Jia R.; Wu F.H.; Experiment of tumor inhibition of Ciliate Bugle Herb in S180 sarcom mice. J Fujian College of TCM 2003,13(2),30-31","journal-title":"J Fujian College of TCM"},{"key":"ref=23","first-page":"94","volume":"23","author":"Peng B.","year":"2017","unstructured":"Peng B.; He R.; Han J.Y.; Yang Y.F.; Xu Q.H.; Li J.R.; Intervention effect of Ajuga decumbens Iridoids on character-istics of breast cancer stem cells via ERK MAPK and PI3K\/Akt signaling pathways. Zhongguo Shiyan Fangjixue Zazhi 2017,23(18),94-99","journal-title":"Zhongguo Shiyan Fangjixue Zazhi"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1039\/a809656b","volume":"36","author":"Tominaga H.","year":"1999","unstructured":"Tominaga H.; Ishiyama M.; Ohseto F.; Sasamoto K.; Hamamoto T.; Suzuki K.; Watanabe M.A.; Water-soluble te-trazolium salt useful for colorimetric cell viability assay. Anal Commun 1999,36(2),47-50","journal-title":"Anal Commun"},{"key":"ref=25","first-page":"19","volume":"9","author":"Yang Y.","year":"2021","unstructured":"Yang Y.; Yong J.P.; Olatunde O.Z.; Lu C.Z.; Chemical com-ponents isolated from the leaves of Podocarpus nagi planted in Fujian and preliminary in vitro anticancer activity. Acad J Med Plants 2021,9(2),19-22","journal-title":"Acad J Med Plants"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.13005\/bpj\/2134","volume":"14","author":"Xiao Y.C.","year":"2021","unstructured":"Xiao Y.C.; Yong J.P.; Yang Y.; Lu C.Z.; The ethyl acetate extraction obtained from Podocarpus Nagi kernel Meal with anticancer activity. Biomed Pharmacol J 2021,14(1),363-366","journal-title":"Biomed Pharmacol J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/pca.671","volume":"13","author":"Coll J.","year":"2002","unstructured":"Coll J.; NMR shift data of neo-clerodane diterpenes from the genus Ajuga. Phytochem Anal 2002,13(6),372-380","journal-title":"Phytochem Anal"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.2174\/1871520615666150305103122","volume":"15","author":"Yong J.","year":"2015","unstructured":"Yong J.; Lu C.; Wu X.; Synthesis of isoxazole moiety con-taining thieno[2,3-d]-yrimidine derivatives and preliminarily in vitro anticancer activity (Part II). Anticancer Agents Med Chem 2015,15(9),1148-1155","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2174\/1871520615666150526115904","volume":"15","author":"Yong J.","year":"2015","unstructured":"Yong J.; Lu C.; Wu X.; Synthesis and biological evaluation of quinazoline derivatives as potential anticancer agents (II). Anticancer Agents Med Chem 2015,15(10),1326-1332","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1871520614666140812105445","volume":"15","author":"Yong J.P.","year":"2015","unstructured":"Yong J.P.; Lu C.Z.; Wu X.; Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline deriva-tives and preliminarily in vitro anticancer activity. Anticancer Agents Med Chem 2015,15(1),131-136","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=31","author":"Lu C.Z.","year":"2015","unstructured":"Lu C.Z.; Yong J.P.;  Quinazoline derivatives and application thereof. U. S. patent 9,193,718B2, 2015"},{"key":"ref=32","author":"Yong J.P.","year":"2017","unstructured":"Yong J.P.; Lu C.Z.; Ferrocene drivatives, preparation method and use thereof. U. S. patent 9,738,673B1  2017"},{"key":"ref=33","author":"Lu C. Z.","year":"2016","unstructured":"Lu C. Z.; Yong J. P.; Thieno[2,3-d]Pyrimidine derivatives, preparation method and use Thereof. U. S patent 9,434,741B2,  2016"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520622666220620151225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206214\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520622666220620151225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:48:58Z","timestamp":1678970938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206214\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520622666220620151225","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}